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Materials and Methods: 
Development of Mammalian Vectors for Expression of E. coli NLL-MetRS/tRNAMet.  For PCR and cloning 
purposes, unless otherwise stated, we used chemically competent E. coli MegaX DH10B (Zymo 
Research). Plasmid DNA was purified using a Miniprep kit (Qiagen); colony selection was performed on 
LB-agar plates with 100 µg/mL ampicillin. All plasmids were verified by sequencing (Laragen). The E. coli 
NLL-MetRS was obtained from pAM1 (Addgene plasmid 51401) through PCR amplification using a Nhe1 
forward primer and an Xho1 reverse primer and inserted into the multiple cloning site of the 
mammalian expression vector pCDNA3.1+ (Invitrogen). This vector contains a CMV promoter, a bovine 
growth hormone (BGH) transcriptional stop sequence, and a neomycin resistance gene for G418 
selection. The resulting plasmid was designated pMetRSNLL_G. For simultaneous expression of E. coli 
tRNAMet and NLL-MetRS, the E. coli elongator tRNAMet sequence was synthesized (Integrated DNA 
Technologies) with the 5’ and 3’ flanking sequences of human tRNAfMet as well as flanking BglII 
restriction sites. This construct was inserted into the BglII site in pMetRSNLL_G to produce 
pMetRSNLLtRNA_G (sequence included in Figure S8). pMetRSNLLtRNA_G is a pCDNA3.1+-based vector 
expressing the NLL-MetRS under CMV promoter control as well as the E. coli tRNAMet. A second tRNA 
sequence lacking the C-terminal CCA tail was synthesized (Integrated DNA Technologies) and inserted 
into the BglII restriction site of MetRSNLL_G to make pMetRSNLLtRNAdcca_G (sequence included in 
Figure S9).   
Introduction of Mutations into MaRS and Development of Associated Mammalian Expression Vectors. 
MaRS was obtained from a cDNA clone from American Type Culture Collection clone ID 6414029 (ATCC). 
Site-directed mutagenesis (Agilent) was used to introduce the NLL, CLL, PLL and SLL mutations at 
residues L274, Y527 and H562 respectively. The L274G mutation was also introduced. These sequences 
were PCR amplified with a Nhe1 forward primer and an Xho1 reverse primer and inserted into 
pCDNA3.1+ (Invitrogen), resulting in plasmids pMaRSWT_G, pMaRSL274G_G/pMaRS_G, pMaRSSLL_G, 
pMaRSPLL_G, pMaRSCLL_G, pMaRSNLL_G (sequences in Figures S1-S6, respectively).  
Development of Expression Vectors for Cell-Selective Proteomic Labeling and Cre-Lox Mediated 
Expression of L274GMmMetRS. To prepare pMaRSC, the L274G MaRS coding sequence was connected 
to a mCherry sequence through a T2A linker by sewing PCR. Briefly, the MaRS sequence (obtained from 
pMaRSL274G_G/pMaRS) was PCR amplified using a Nhe1 forward primer containing a Flag-Tag 
sequence and a reverse primer containing a T2A linker. The mCherry coding sequence was amplified 
using a matching T2A sequence in the forward primer and a reverse primer encoding a C-terminal Myc-
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tag and stop codon. Sewing PCR was used to amplify the final product with the following sequence 
components: Nhe1-FlagTag-MaRS-T2A-mCherry-MycTag-Xho1. This sequence was inserted between the 
Nhe1 and Xho1 sites of a pCDNA3.1+ vector containing a hygromycin resistance cassette (Invitrogen) to 
yield pMaRSC (sequence in Figure S12). For Cre-Lox mediated recombination, a LoxP-flanked 
transcriptional stop sequence was inserted after the CMV promoter in the pMaRSC plasmid. The LoxP-
flanked transcriptional stop sequence consisting of forward LoxP 
(ATAACTTCGTATAGCATACATTATACGAAGTTAT) sequences flanking the transcriptional stop sequence 
was synthesized with Nhe1 restriction sites on both ends (Integrated DNA Technologies). The resulting 
fragment was ligated into the Nhe1 site of pMaRSC to yield the Cre-Lox plasmid pMaRSC_lox_H 
(sequence in Figure S13). The correct orientation of the insert into the Nhe1 cut site was verified by 
sequencing.  
Cell Culture.  Cells were passaged every three days on tissue-culture plates and incubated at 37°C and 
5% CO2. CHO-K1 cells were maintained in RMPI (Invitrogen) medium with 10% fetal bovine serum, and 
supplemented with Pen/Strep, L-glutamine and non-essential amino acids (Invitrogen). HeLa and COS7 
cells were cultured in DMEM (Invitrogen) medium with 10% fetal bovine serum, and supplemented with 
Pen/Strep, L-glutamine and non-essential amino acids (Invitrogen).  
Cell Transfection, Selection and Conditional Transgene Activation. Mammalian expression plasmids 
were amplified in E. coli strain MegaX DH10B and purified by using endotoxin-free plasmid Maxi-kits 
(Qiagen). Lipofectamine 2000 (Invitrogen) was used for all transfections according to the manufacturer’s 
recommended procedures. For identification of MetRS variants that charge Anl and to study Anl 
incorporation, all cells were transiently transfected 30 hours prior to Anl labeling. For the Cre-Lox 
transgene activation study, pMaRSC_lox_H was linearized with BglII and transfected into CHO cells. After 
selection on hygromycin at 100 µg/ml for 10 days, surviving colonies were picked and expanded to yield 
a stable cell line. Cre-mediated recombination in these cells was achieved through transient transfection 
with a plasmid expressing eGFP-Cre under control of an EF1α promoter (Addgene plasmid 11923).  
Synthesis of Azidonorleucine. Azidonorleucine synthesis was based on a previous protocol for 
azidohomoalanine synthesis, using Boc-lysine as the starting material.1  
Copper-Catalyzed Reaction of Alkyne-TAMRA with Anl-labeled Proteins in Cell Lysates and Detection 
by In-gel Fluorescence. Cells were lysed with 4% SDS in phosphate-buffered saline (PBS). 
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Ethylenediaminetetraacetic acid (EDTA)-free protease inhibitor (Roche) was added to the lysates to 
reduce protease activity. PBS was added to dilute the SDS concentration to 1%, and cell lysates were 
centrifuged at 14,000 rcf for 10 minutes to remove cellular debris. Protein concentrations were 
measured by using a bicinchoninic protein quantification kit (BCA assay; Pierce). The same amount of 
protein was used for each condition; concentrations ranged from 0.1 to 0.4 mg/mL.  Copper-catalyzed 
reactions were performed using the Click-IT TAMRA protein analysis kit (Invitrogen). Proteins were 
precipitated with chloroform/methanol, washed with methanol to remove unreacted dye and 
resuspended in protein loading buffer containing 2% SDS and 10 mM 2-mercaptoethanol. Proteins were 
separated by electrophoresis on 12% Bis-Tris polyacrylamide gels (Invitrogen). TAMRA (λexcitation = 555 nm 
and λemission = 580 nm) was excited at 532 nm and detected with a 580 band-pass 30 nm filter. In-gel 
fluorescence images were acquired on a Typhoon 9400 molecular imager (GE Healthcare).  
Detection of Proteins in Gels and Western Blots. Bicinchoninic acid protein quantification (Pierce) was 
used to equalize the amounts of proteins analyzed under different conditions. After dye labeling via the 
copper-catalyzed click reaction described above, proteins were washed with methanol to remove 
unreacted dye and then separated on Novex 12% Bis-Tris polyacrylamide gels (Invitrogen). Colloidal blue 
dye (Invitrogen) was used for nonspecific protein detection. For Western blots the proteins were 
transferred to nitrocellulose membranes (GE Healthcare), and probed with a Myc-tag-Alexa Fluor 488 
conjugate monoclonal antibody (Cell Signal Technologies) at 1:1000 dilution in PBS with 0.2% v/w 
Tween20 (Sigma). Imaging of Western blots and gels was performed with a Typhoon 9400 molecular 
imager (GE Healthcare).  
Copper-Catalyzed Reaction of Alkyne-TAMRA in Adherent Cells and Fluorescence Confocal 
Microscopy. Copper-catalyzed azide-alkyne cycloaddition reactions and synthesis of requisite THPTA 
ligand were performed as described previously1,2. Adherent CHO cells seeded onto glass bottom tissue 
culture plates (MatTek) were incubated in fresh CHO medium, as described above, supplemented with 
Anl at 1.5 mM, for 6 hours. Cells were washed twice with PBS, fixed with 3.7% formaldehyde in PBS for 
15 minutes at room temperature, permeabilized with 4°C methanol for 10 minutes, and washed three 
times with PBS at room temperature. Labeling with alkyne-TAMRA (Invitrogen) was performed at room 
temperature in pH 7.4 PBS for 2 hours, using a final concentration of 0.1 mM copper sulfate, 0.5 mM 
THPTA, 5 mM sodium ascorbate, 5 mM aminoguanidine and 10 µM alkyne-TAMRA. To remove 
unreacted dye and other reaction components, cells were washed five times at 30-min intervals with 
PBS. Cell nuclei were stained with 300 nM DAPI in PBS for 30 min at room temperature and washed 
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three times with PBS before imaging. Fluorescence confocal images were obtained on a Zeiss LSM 510 
microscope.  
Identification of Anl Incorporation Sites in Cellular Proteins.  
HeLa cells expressing L274GMmMetRS were labeled for a total of 10 hours with 2mM Anl before 
proteomic analysis. Cells were lysed with 1% SDS in PBS supplemented with EDTA-free protease 
inhibitor (Roche). Lysates was sonicated using a tip sonicator to reduce viscosity and centrifuged at 
14,000 rcf for 15 min to remove cellular debris and reacted with an acid-cleavable biotin-alkyne 
enrichment tag for 2 hours, using a final concentration of 0.1 mM copper sulfate, 0.5 mM THPTA ligand, 
5 mM sodium ascorbate, 5 mM aminoguanidine, and 100 µM alkyne probe. To identify sites of Anl 
incorporation in proteins, we used a cleavable enrichment tag that would allow detection of Anl and 
tagged-Anl residues at Met positions. This acid-cleavable biotin-alkyne enrichment tag was previously 
reported by us3 and has the following structure: 
 
After click reaction with this tag, proteins were precipitated with acetone, dissolved in 250 µl of 4% SDS 
in PBS, and diluted to 0.1% SDS by addition of PBS supplemented with EDTA-free protease inhibitor 
(Roche). Proteins were incubated with 400 µl Streptavidin Plus Ultralink resin (Pierce) for 1.5 hours at 
room temperature. Affinity purification was performed according to a previously published protocol4 
and the tag was cleaved in mild acidic solution, the resulting cleaved tag structure after reaction with 
Anl residue is as follows: 
 
This tag structure introduces a mass shift of 121.12 amu at each methionine position, this variable mass 
modification includes the mass shift from methionine to Anl and the triazole conjugate containing the 
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cleaved tag moiety. We used this mass shift in our mass spectrometric analysis as a variable mass 
modification to search for Anl incorporation at Met positions in proteins.   
 
Tryptic Digest for Identification of Anl Incorporation Sites. After enrichment as described above, 
elution fractions were combined with Amicon Ultra 0.5 centrifuge filters (3 kDa MWCO) (Millipore), and 
resuspended in 200 µL Tris-HCl pH 8.5. Lysyl endopeptidase (Wako; 10 µL of 0.1 µg/µL solution in 100 
mM Tris-HCl pH 8.5) was added, and the sample was incubated for 4 hours at room temperature in the 
dark. Thereafter 20 µL of 0.5 µg/µL trypsin (Wako) in water was added and the sample was incubated in 
the dark overnight at room temperature.  The eluent was centrifuged at 14000 rcf for 20 min using a 10 
kDa molecular weight cutoff spin filter (Pierce) to remove undigested proteins as well as trypsin which 
remains in the filter. The flow-through, which contained tryptic peptides, was retained and acidified to 
0.2% CF3COOH. The peptide solution was desalted as described by Mann and coworkers
5 using a 3 mL 
MILI-SPE C18-SD extraction disk cartridge (3M) as follows. The cartridge was washed with 1 mL CH3OH 
and centrifuged at 1500 rcf for 1 min, washed with 0.5 mL 0.1% CF3COOH, 70% CH3CN in water, and 
centrifuged at 1500 rcf for 1 min. The cartridge was washed with 0.1% CF3COOH in water and 
centrifuged at 1500 rcf for 1 min. The peptide sample was loaded into the cartridge and passed through 
three times; each time the cartridge was centrifuged at 150 rcf for 3 min. The cartridge was washed 
twice with 0.5 mL 0.1% CF3COOH in water and centrifuged at 150 rcf for 3 min. To elute the desalted 
peptides, the cartridge was washed with 0.5 mL of CH3CN in water and centrifuged at 150 rcf for 3 min. 
The desalted peptides were lyophilized and stored at 4°C before analysis by mass spectrometry.   
 
Affinity Enrichment of Anl-labeled Proteins for Shotgun Proteomics. Cells were labeled for a total of 24 
hours with 2 mM Anl, then washed with PBS and lysed with 1% SDS in PBS supplemented with EDTA-free 
protease inhibitor (Roche) and 100 mM chloroacetamide. Lysates were boiled for 10 minutes at 95°C, 
and centrifuged at 14,000 rcf for 30 minutes to remove cellular debris. The supernatant protein content 
was quantified using the bicinchoninic acid assay. For each enrichment, 3 mg of lysate was combined 
with 50 µL of azadibenzocyclooctyne resin (50% slurry by volume; Click Chemistry Tools) that had been 
washed three times with 0.8% SDS in PBS. This copper-free on-resin cycloaddition reaction was 
incubated at room temperature on a rotating table for 3 hours, and then unreacted DBCO groups were 
quenched by addition of 20 µL 100 mM Anl for 30 minutes. The supernatant was then removed, and the 
beads washed with 1 mL H2O, reduced with 0.5 mL DTT (1 mM, 15 minutes at 70°C), and alkylated with 
0.5 mL iodoacetamide (40 mM, 30 minutes at room temperature, protected from light). The resin was 
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then washed extensively to remove non-specifically bound proteins, using 40 mL each of 0.8% SDS in 
PBS, 8 M urea in 100 mM tris (pH 8.0), and 20% acetonitrile (in 5 mL aliquots). After washing, the resin 
was transferred to an eppendorf with 100 µL trypsin digestion buffer (10% acetonitrile in 50 mM 
ammonium bicarbonate). This was supplemented with 0.1 ug of sequencing grade trypsin, and 
incubated with shaking at 37°C overnight to digest the resin-bound proteins. The supernatant was then 
collected, combined with two washes of the resin (150 µL 10% acetonitrile each), and lyophilized. To 
investigate the non-specific background of this enrichment, this same protocol was also carried out on 
cells that had been pulsed with 2 mM methionine instead of Anl. 
 
Sample Preparation for Shotgun Proteomics. After affinity enrichment, digested peptides were 
resuspended in 100 uL of 50 mM ammonium bicarbonate, treated with a HiPPR detergent removal spin 
column (Pierce) to remove trace SDS, and desalted with a C18 ZipTip (EMD Millipore). The eluate was 
lyophilized, and resuspended in 0.2% formic acid for LC-MS/MS analysis. An aliquot of each sample was 
diluted in water and quantified using the LavaPep Fluorescent Protein and Peptide Quantification Kit 
(Gel Company), to estimate the appropriate volume to analyze by mass spectrometric analysis. 
 
Mass Spectrometry. Analyses were performed on a hybrid LTQ-Orbitrap Elite (Thermo Fisher Scientific) 
equipped with a nanoelectrospray ion source connected to an EASY-nLC II instrument (Thermo Fisher 
Scientific) as described previously6. Separation of peptides was performed using a 15-cm reversed phase 
analytical column (75 μm ID) with 3 μm C18 beads (ReproSil-Pur C18-AQ) with a gradient of 2% solvent B 
for 5 minutes followed by an increase from 2% to 30% in 115 min and lastly a sharp rise to 100% B in 1 
min. Solvent A was 0.2% formic acid, 2% acetonitrile, 97.8% LC-MS water and solvent B was 0.2% formic 
acid, 80% acetonitrile, 19.8% LC-MS water. The mass spectrometer was operated in data-dependent 
mode. Survey full scan mass spectra were acquired with a resolution of 120,000 at 400 m/z. The top 20 
most intense ions from the survey scan were isolated and, after the accumulation of 5000 ions, 
fragmented in the linear ion trap by collision induced dissociation. Precursor ion charge state screening 
was enabled and singly charged and unassigned charge states were rejected. The dynamic exclusion list 
was enabled with a relative mass window of 10 ppm. An additional exclusion list included common 
trypsin peptide masses. Data analysis was performed using MaxQuant software (v. 1.5.3.8).7 Spectra 
were extracted from the raw files using MaxQuant with match between runs. Spectra were searched 
against UniProt Chinese Hamster database (23888 entries) and a contaminant database (246 entries). 
Digestion enzyme was specified as trypsin with up to two missed cleavages. Variable modifications 
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included methionine oxidation (+15.9949), N-terminal protein acetylation (+42.0106), Met to Anl 
(+23.0450), and Met to Anl to Lys modification (-2.9455) and a fixed modification of cysteine 
carbamidomethylation (+57.0215). The Met to Anl to Lys modification is for residues in which Anl is 
incorporated at Met codons, wherein the azide side chain of this Anl does not form a triazole linkage 
during cycloaddition reaction, and it is reduced to a primary amine during proteomics workup and 
sample preparation. Precursor mass tolerance was less than 4.5 ppm after mass recalibration by 
MaxQuant. Fragment ion tolerance was 0.5 Da. Protein and peptide false discovery rates were fixed at 
1% and estimated using a decoy database search performed by MaxQuant. Annotation of proteins into 
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Figure S1. The pMaRSWT_G vector for expression of wild-type MmMetRS under CMV promoter 
control. Restriction enzymes are highlighted in yellow and the enzyme coding sequence is highlighted in 
green. Kozak sequence is highlighted in blue.  The expressed protein sequence is included after the 

































ORF frame 3 5639..5103


























































































































Figure S2. The pMaRSL274G_G vector for expression of L274GMmMetRS under CMV promoter 
control. Restriction enzymes are highlighted in yellow and the enzyme coding sequence is highlighted in 
green. Kozak sequence is highlighted in blue. The expressed protein sequence is included after the 































ORF frame 3 5639..5103



























































































































Figure S3. The pMaRSSLL_G vector for expression of SLL-MmMetRS under CMV promoter control. 
Restriction enzymes are highlighted in yellow and the enzyme coding sequence is highlighted in green. 


































ORF frame 3 5639..5103

























































































































Figure S4. The pMaRSPLL_G vector for expression of PLL-MmMetRS under CMV promoter control. 
Restriction enzymes are highlighted in yellow and the enzyme coding sequence is highlighted in green. 

























ORF frame 3 5639..5103

































































































































Figure S5. The pMaRSCLL_G vector for expression of CLL-MmMetRS under CMV promoter control. 
Restriction enzymes are highlighted in yellow and the enzyme coding sequence is highlighted in green. 


























ORF frame 3 5639..5103

































































































































Figure S6. The pMaRSNLL_G vector for expression of NLL-MmMetRS under CMV promoter control. 
Restriction enzymes are highlighted in yellow and the enzyme coding sequence is highlighted in green. 





























ORF frame 3 5639..5103






























































































































Figure S7. The pMetRSNLL_G vector for expression of the E. coli NLL-MetRS under CMV promoter 
control. Restriction enzymes are highlighted in yellow, start codon in red, and the enzyme coding 
sequence is highlighted in green. Kozak sequence is highlighted in blue. The expressed protein sequence 


























ORF frame 3 4964..4428
ORF frame 3 4119..4913
NeoR/KanR 4122..4910
Ampicillin 7275..6415


















































































































Figure S8. The pMetRSNLLtRNA_G vector for expression of the E. coli NLL-MetRS under CMV promoter 
control. Restriction enzymes are highlighted in yellow, start codon in red, and the enzyme coding 
sequence is highlighted in green. Kozak sequence is highlighted in blue. The expressed protein sequence 
is included after the plasmid sequence. This plasmid also contains the tRNA expression cassette as 
outlined in Figure 1b of the main text. The tRNA cassette was inserted into the BglII restriction site in the 






































ORF frame 3 5085..4549












































































































Figure S9. The pMetRSNLLtRNAdcca_G vector for expression of the E. coli NLL-MetRS under CMV 
promoter control. Restriction enzymes are highlighted in yellow, start codon in red, and the enzyme 
coding sequence is highlighted in green. Kozak sequence is highlighted in blue. The expressed protein 
sequence is included after the plasmid sequence. This plasmid also contains the tRNA expression 
cassette as outlined in Figure 1b of the main text, wherein the CCA tail of the tRNA was removed in this 





























ORF frame 3 5081..4545
















































































































































Protein loading controls corresponding to Figure 1(d) of the main text. Cell lysate proteins which were 
labeled with TAMRA-alkyne dye and electrophoresed on a polyacrylamide SDS gel were subsequently 
stained with colloidal blue dye to determine the relative abundances of proteins in lysates derived from 




Figure S12. Selectivity of L274GMmMetRS. In-gel fluorescence was used as a measure of Anl 
incorporation into cellular proteins. At a fixed concentration of Met, changes in Anl concentration 
determine the extent of protein labeling, which depends on the relative rates of activation of Anl and 
Met by L274GMmMetRS. 








→  𝐸 + 𝑃𝐴                (1) 





 𝐸𝑆𝑀  
𝑘2
𝑀
→  𝐸 + 𝑃𝑀              (2) 
 
where 𝐸𝑆𝐴 is the complex of L274GMmMetRS with Anl (A) and 𝐸𝑆𝑀 is the complex of L274GMmMetRS 
with Met (M). 𝑃𝐴 is tRNA
Met charged with Anl; 𝑃𝑀 is tRNA
Met charged with Met. 
 



















where VA and VM are the rates of activation of Anl and Met, respectively. 
For a fixed Anl concentration the total rate of substrate activation by L274GMmMetRS is a constant (C): 
 𝐶 = 𝑉𝐴 + 𝑉𝑀 
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) is the selectivity, C is a constant and the Met and Anl concentrations are known. Measured 
values of in-gel fluorescence were fit to Equation 5 by least-squares methods at different concentrations 
of Anl and Met to determine the selectivity of L274GMmMetRS.  
The following Matlab functions were used to fit the data from Figure 2A in the main text.  The resulting 




Figure S12A. Selectivity of L274GMmMetRS. In-gel fluorescence was used as a measure of Anl 
incorporation into cellular proteins. At a fixed concentration of Met, changes in Anl concentration 
determine the extent of protein labeling, which depends on the relative rates of activation of Anl and 
Met by L274GMmMetRS. 
-------------------------------- 
function fitfluorescenceR 






     
A=[0; 0.5; 1;  2; 4]; 
fl=[0.022871044;    0.516731636;    0.699062794; 0.752107911;   1] 
err=[0.002135075;   0.086032748;    0.127708537;    0.098922244;    0.183627695]; 
errorbar(A,fl,err,'ro'); 
  
% initial guess for parameters 
x0=[0.5 1] % This is the selectivity parameters 
% second 1 this is constant C 
[x,resnorm, residual,~,exitflag,output]=lsqcurvefit(@FF,x0,A,fl); 
hold on 




SStotal = (length(fl)-1) * var(fl); 
SSresid=sum(residual.^2); 










We tested the selectivity parameters that we obtained from Figure 2A to compare the predicted and 
observed Anl incorporation levels at the different Met concentrations used in Figure 2B. The following 
Matlab functions were used for Figure 2B in the main text. The data in Figure 2B were first normalized 
so that at a Met concentration of 0.15 mM, the level of Anl incorporation corresponds to that of Figure 
2A; the concentration of Met used in Figure 3A is a constant 0.15 mM.  
 
Figure S12B. Selectivity of L274GMmMetRS. In-gel fluorescence was used as a measure of Anl 
incorporation into cellular proteins at a fixed Anl concentration with varying concentrations of Met. 
Selectivity parameters that were obtained from Figure 2A were used to obtain the predicted Anl 












M=[0.15;    0.3;    0.75;   1.5]; 
fl=[0.7;    0.548851071;    0.263135683;    0.14119813]; 
err=[0.086722315;   0.112658654;    0.19100414; 0.11272512]; 
errorbar(M,fl,err,'ro'); 
  




SStotal = (length(fl)-1) * var(fl); 
SSresid=sum(residual.^2); 







Figure S13. The pMaRSC vector for expression of L274GMmMetRS and mCherry proteins. The cassette 
inserted into the Nhe1/Xho1 restriction sites of the pcDNA3.1 plasmids is color coded corresponding to 
highlighted sequences. Kozak sequence is highlighted in light blue.The pMaRS plasmid is the same 
construct as pMaRSL274G, and below is the sequence for pMaRSC which contains a T2A-Mcherry 






































ORF frame 3 5568..6593









































































































































Figure S14. The pMarlox vector for expression of L274GMmMetRS and mCherry proteins. The cassette 
inserted into the Nhe1/Xho1 restriction sites of the pcDNA3.1 plasmids is color coded corresponding to 
highlighted sequences. Kozak sequence is highlighted in blue. The loxP sequences and transcriptional 



































ORF frame 3 5870..6895


























































































































































Figure S15. Western blot for detection of L274GMmMetRS and Anl labeled proteins. Metabolic 
incorporation of Anl by pMaRS- and pMaRSC-transfected CHO cells. The in-gel fluorescence image on 
top shows TAMRA labeling, which indicates Anl incorporation. Western blot at the bottom using anti-
Myc antibody shows the detection of mCherry at approximately 25 kDa. 
 
Western blot using a Myc-tag-Alexa Fluor 488 conjugate monoclonal antibody was used to probe for 
mCherry in lystes of CHO cells transfected with pMaRSC and pMaRS vectors. The pMaRSC lane shows a 
protein band at approximately 25 kDa corresponding to mCherry and no other bands at higher 
molecular weights indicating that mCherry is not fused to L274GMmMetRS. The pMaRS vector lacks the 
mCherry sequence and as anticipated we do not observe a protein band corresponding to mCherry in 
the cell lysates.   





Figure S16. Identification of Anl-labeled proteins by tandem mass spectrometry and annotation in 
terms of cellular components using STRAP software. BONCAT was used to identify proteins made in 
CHO cells that constitutively express the L274GMmMetRS under control of the CMV promoter. Cells 
were labeled in media containing either 2 mM Anl or with 2 mM Met. The Met samples were used to 
account for proteins that bind non-specifically to the resin during enrichment. Two biological replicates 
were performed for each amino acid with independent mass spectrometric runs for each. The charts 
below show the distributions of proteins identified in the Anl-labeled samples.  
Replicate 1 (884 proteins) 
 
Replicate 2 (959 proteins) 
 
The proteins identified in either of the Met samples were removed from the list of proteins identified in 
either of the Anl samples. The result of this analysis is shown in the chart below and included in the 
main text in Figure 3d. 






Figure S17. Assessment of enrichment and reproducibility in BONCAT analysis. The extent to which 
BONCAT allows enrichment of newly synthesized proteins was assessed by comparing the numbers of 
proteins found in Anl- and Met-treated samples, and by comparing spectral counts. We identified a total 
of 847 proteins that were found in both Anl replicates, of which 724 were not present in the Met 
controls. There were 129 proteins that were in both Met samples (a). Combining the total proteins 
identified in either of the Anl samples resulted in 996 proteins, 786 of which were not present in either 
of the Met samples (b). Comparison of the proteins identified in the two Anl replicates (c) and the two 
Met replicates (d) shows low sample-to-sample variability for the Anl replicates. Reproducibility of 
quantified protein levels across biological replicates was determined using MaxQuant’s label-free 
quantification (LFQ) value. LFQ serves as a normalized measure of relative protein abundance. These 
results are shown as dot plots of LFQ levels between Anl replicates (e) and Met replicates (f). On 
average, we observed 19-fold more spectral counts for Anl samples than for Met samples (g). The 




Figure S18. Incorporation of Anl at terminal and internal Met sites in HeLa cells. According to UniProt 
(http://www.uniprot.org/), there are 711,731 internal and 79,802 N-terminal Met residues in the human 
proteome; internal Met sites constitute 90% of the total. Mass spectrometric analysis of proteins made 
in HeLa cells expressing the L274GMmMetRS (see table S2 for protein list) identified 161 sites of Anl 
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